Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Trends in opioid use following balloon kyphoplasty or vertebroplasty for the treatment of vertebral compression fractures

Open access
Ni, W., Ricker, C., Quinn, M., Gasquet, N., Janardhanan, D., Gilligan, C.J., Hirsch, J.A. · 2022 · Osteoporosis International

Abstract

This retrospective analysis of insurance claims evaluated real-world trends in prescription fills among patients treated with balloon kyphoplasty (N = 6,656) or vertebroplasty (N = 2,189) following diagnosis of vertebral compression fracture. Among those with evidence of opioid use, nearly half of patients discontinued or reduced prescription fills relative to pre-operative levels. INTRODUCTION: Vertebral compression fractures (VCF) are associated with debilitating pain, spinal misalignment, increased mortality, and increased healthcare-resource utilization in elderly patients. This study evaluated the effect of balloon kyphoplasty (BKP) or vertebroplasty (VP) on post-procedure opioid prescription fills and payer costs in patients with VCF. METHODS: This was a retrospective analysis of a large, nationally representative insurance-claims database. Clinical characteristics, opioid prescription patterns, and payer costs for subjects who underwent either BKP or VP to treat VCF were evaluated beginning 6 months prior to surgery through 7-month follow-up that included a 30-day, postoperative medication washout. Patient demographics, changes in opioid utilization, and payer costs were analyzed. RESULTS: A total of 8,845 patients met eligibility criteria (75.3% BKP and 24.7% VP) with a mean of age 77 and 74% female. Among the 75% of patients who used opioids, 48.7% of patients discontinued opioid medication and 8.4% reduced prescription fills versus preoperative baseline. Patients who reduced or discontinued prescriptions exhibited a decrease in all-cause payer costs relative to pre-intervention levels, which was a significantly greater change relative to patients with no change, increase, or new start of opioids. CONCLUSIONS: Interventional treatment for VCF was associated with decreased or discontinued opioid prescription fills and reduced payer costs in follow-up in a significant proportion of the study population. Reduction of opioid-based harms may represent a previously unrecognized benefit of vertebral augmentation for VCF, especially in this elderly and medically fragile population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00198-021-06163-3

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Patient distribution among opioid prescription* categories before and after vertebral augmentation procedures (balloon kyphoplasty or vertebroplasty) and absolute change from baseline. *Opioid prescription fills during the washout period was excluded from analysis. Subjects with no evidence of opioid prescription fills during any phase of the study were also excluded. Opioid prescription categories, expressed in daily MME: none, low (< 2 mg/day), moderate (2 to < 7 mg/day), and high (≥ 7 mg/day)
Fig. 1 Patient distribution among opioid prescription* categories before and after vertebral augmentation procedures (balloon kyphoplasty or vertebroplasty) and absolute change from baseline. *Opioid prescription fills during the washout period was excluded from analysis. Subjects with no evidence of opioid prescription fills during any phase of the study were also excluded. Opioid prescription categories, expressed in daily MME: none, low (< 2 mg/day), moderate (2 to < 7 mg/day), and high (≥ 7 mg/day)CC BY-NC · PubMed Central
Fig. 2 Opioid prescription days (A) and average daily dose, in MME (B) before and after vertebral augmentation, by opioid prescription trend.* *Vertical dashed line: index procedure date. Opioid prescription fills during the washout period were excluded from analysis. Patients with no evidence of opioid prescription fills during study period were also excluded
Fig. 2 Opioid prescription days (A) and average daily dose, in MME (B) before and after vertebral augmentation, by opioid prescription trend.* *Vertical dashed line: index procedure date. Opioid prescription fills during the washout period were excluded from analysis. Patients with no evidence of opioid prescription fills during study period were also excludedCC BY-NC · PubMed Central
Fig. 3 Difference in adjusted all-cause payer costs in follow-up versus baseline, stratified by opioid prescription trend after a vertebral augmentation procedure. Opioid prescription fills during the washout period was excluded from analysis. Subjects with no evidence of opioid prescription fills during study period were also excluded
Fig. 3 Difference in adjusted all-cause payer costs in follow-up versus baseline, stratified by opioid prescription trend after a vertebral augmentation procedure. Opioid prescription fills during the washout period was excluded from analysis. Subjects with no evidence of opioid prescription fills during study period were also excludedCC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 10

Metadata

Authors
Ni, W., Ricker, C., Quinn, M., Gasquet, N., Janardhanan, D., Gilligan, C. J., & Hirsch, J. A.
Affiliations
  • Medtronic (United States) (US)
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
Corresponding author
Hirsch, J.A.
Venue
Osteoporosis International
Published
2021-11-02
Volume
33
Issue
4
Pages
821-837
ISSN
  • 0937-941X (ISSN-L)
  • 1433-2965
OpenAlex
W3208009188
Cited by
10
References
45
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3
FWCI
1.88
Type
journal article
Language
en
Open access
Licence
Locations
  • Osteoporosis International (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Spinal Fractures and Fixation Techniques
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
vertebral compression fractures, balloon kyphoplasty, vertebroplasty, opioid discontinuation, vertebral augmentation, health care costs, elderly patients, pain management
MeSH terms
Aged, Analgesics, Opioid, Female, Humans, Male, Retrospective Studies, Spinal Fractures, Treatment Outcome, Fractures, Compression, Vertebroplasty, Kyphoplasty, Osteoporotic Fractures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends in opioid use following balloon kyphoplasty or vertebroplasty for the treatment of vertebral compression fractures. https://app.cochat.ai/papers/10.1007/s00198-021-06163-3
The paper
Ni, W., Ricker, C., Quinn, M., Gasquet, N., Janardhanan, D., Gilligan, C. J., & Hirsch, J. A. (2022). Trends in opioid use following balloon kyphoplasty or vertebroplasty for the treatment of vertebral compression fractures. Osteoporosis International. https://doi.org/10.1007/s00198-021-06163-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.